Abstract
SAT-LB112 An Unusual Case of Ipilimumab/Nivolumab Induced Fulminant Diabetic Ketoacidosis (DKA) in a Non Diabetic Patient - a Case Report
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have